Stockreport

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38Genmab will not [Read more]